AIDX — 20/20 Biolabs, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1139685 ·
Last close
$1.02
Market Cap
$10.69M
52W High
$3.99
52W Low
$0.90
ADV30
384,306
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 538,274 | 130,417 | -912,846 | -1,307,771 | 4,137,357 | 1,025,987 | 4,156,582 |
| Sep 2025 | — | — | — | — | 3,239,449 | 1,144,855 | 3,130,993 |
| Dec 2024 | 536,084 | 163,030 | -1,243,998 | -1,249,048 | 3,584,408 | 1,784,009 | 2,078,926 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,048,118
Investing CF
—
Financing CF
$502,825
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-33,247,219
Inventory
$116,217
Receivables
$199,954
ST Investments
—
EBIT TTM
$-2,431,834
Pretax Income TTM
$-2,556,819
Interest Exp TTM
$124,985
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,844,688
EBITDA
$-3,921,809
Free Cash Flow
$-1,301,893
Enterprise Value
$7,309,924
Total Cash
$4,219,099
Total Debt
$925,487
Shares Out
10,480,089
Trailing EPS
$-0.36
Book Value
$-0.01
ROE
-241.6%
ROA
-58.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,045,133 | -3,330,871 | -3,738,821 | 4,137,357 | 4,156,582 | — | -1,919,720 |
| Dec 2024 | 1,752,343 | -5,661,057 | -5,551,667 | 3,584,408 | 2,078,926 | — | -2,598,785 |
| Dec 2023 | 1,424,304 | -6,361,462 | -6,391,309 | 6,367,828 | 2,080,336 | — | -4,479,971 |
News headlines (Yahoo Finance, 1h cache)
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
2026-05-22 12:31 · Yahoo
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
2026-05-20 20:05 · Yahoo
Sidoti Events, LLC's May Micro-Cap Virtual Conference
2026-05-20 11:30 · Yahoo
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
2026-05-14 12:31 · Yahoo
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
2026-05-12 12:31 · Yahoo
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-13 11:00 · Yahoo
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-04-10 14:00 · Yahoo
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
2026-04-07 12:31 · Yahoo
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
2026-03-31 20:57 · Yahoo
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
2026-03-27 12:31 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.